MEDIANA Co.Ltd vs InBody Co.Ltd: Fair Value & Quality
Both stocks run through our valuation models. Here is how MEDIANA Co.Ltd (041920) and InBody Co.Ltd (041830) compare, as of Aug 10, 2026.
As of Aug 10, 2026, Fair Value Calculator sees InBody Co.Ltd as the less overvalued of the two: MEDIANA Co.Ltd trades at KRW 9,720 versus a fair value of KRW 6,289 (-35%), while InBody Co.Ltd trades at KRW 70,000 versus KRW 49,984 (-29%).
MEDIANA Co.Ltd
041920.KQ · KRW · Health Care
-35%
upside to fair value
overvalued
PriceKRW 9,720
Fair ValueKRW 6,289
Quality61/100
InBody Co.Ltd
041830.KQ · KRW · Health Care
-29%
upside to fair value
overvalued
PriceKRW 70,000
Fair ValueKRW 49,984
Quality71/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
MEDIANA Co.LtdInBody Co.Ltd
Valuation
—Dividend yield1.8%
Profitability
22%Net margin24%
16%Operating margin24%
395%Return on equity—
7%Return on assets11%
Growth
60%Revenue growth (YoY)18%
-1.7%Avg. growth/yr (3Y)13.5%
-0.8%Avg. growth/yr (5Y)16.9%
Balance & size
—Debt / equity0.01×
$126MMarket cap$506M
weakGrowth qualityhealthy
InBody Co.Ltd leads: 1 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
MEDIANA Co.Ltdof which business quality 58 · market factors 45InBody Co.Ltdof which business quality 68 · market factors 83
ProfitabilityMargins and returns on capital today
31
59
Quality GrowthAre margins and returns improving?
65
45
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
55
51
Low VolatilityCalm price path (market factor)
50
43
MomentumPrice trend over the last 3–12 months (market factor)
33
100
52W MomentumDistance to the 52-week high (market factor)
60
100
Net IssuanceBuybacks instead of dilution
56
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
MEDIANA Co.Ltd
DCF ModelsKRW 6,961
Earnings-BasedKRW 3,060
Dividend DiscountKRW 375
MultiplesKRW 5,971
Asset-BasedKRW 4,918
Growth DCFKRW 6,130
Economic ProfitKRW 4,691
Growth EarningsKRW 5,654
26 of 26 models see the stock below the current price.
InBody Co.Ltd
DCF ModelsKRW 65,630
Earnings-BasedKRW 34,626
MultiplesKRW 44,543
Asset-BasedKRW 15,795
Growth DCFKRW 59,979
Economic ProfitKRW 32,522
Growth EarningsKRW 53,096
21 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
MEDIANA Co.Ltd
Bear KRW 4,717Fair Value KRW 6,289Bull KRW 7,861
KRW 9,720 = current price (white tick)
InBody Co.Ltd
Bear KRW 37,377Fair Value KRW 49,984Bull KRW 61,591
KRW 70,000 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
MEDIANA Co.Ltd · Health Care
Quality score61 · above median
Fair value upside-35% · below median
InBody Co.Ltd · Health Care
Quality score71 · Top 25%
Fair value upside-29% · above median
Bottom line
As of Aug 10, 2026, Fair Value Calculator sees InBody Co.Ltd as the less overvalued of the two: MEDIANA Co.Ltd trades at KRW 9,720 versus a fair value of KRW 6,289 (-35%), while InBody Co.Ltd trades at KRW 70,000 versus KRW 49,984 (-29%).
InBody Co.Ltd has the higher quality score (71/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
